Clinical trials
Terminated Phase 3 Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Canadian Urologic Oncology Group | 1 |
| Medstar Health Research Institute | 1 |
| Northwestern University | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Sanofi | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 7 |
| Bipolar Disorder | 2 |
| Psychotic Disorders | 2 |
| Schizophrenia | 2 |
| Arteriosclerosis | 1 |
| Bone Diseases | 1 |
| Carotid Artery Diseases | 1 |
| Carotid Stenosis | 1 |
| Coronary Disease | 1 |
| Obesity | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.